Ardena is a Belgium-based global CDMO that operates six strategically located facilities across Europe and the U.S. The company supports pharmaceutical clients from discovery through clinical trials, offering integrated services in API and nanomedicine development, solid-state chemistry, analytical and formulation development, and drug product manufacturing. Ardena also provides program management and CMC regulatory support, with specialized expertise in cGMP RNA manufacturing and LNP formulation. In 2023, the company partnered with mRNA specialist RiboPro to strengthen its RNA synthesis and encapsulation capabilities.